Valisure’s CEO, David Light and CSO, Kaury Kucera– in collaboration with Agilent, a global leader in manufacturing analytical laboratory equipment – participate in a webinar on identifying benzene in various ways consumer products and how Valisure provides independent quality assurance throughout the supply chain.
In late 2020, Valisure expanded its testing capabilities to include analysis for benzene and has since announced its detection of the carcinogen in multiple consumer products, including hand sanitizers, sunscreens, and body sprays, prompting several global recalls.
Valisure increasingly works directly with major stakeholders in healthcare, including purchasers and manufacturers of drug and consumer healthcare products, to infuse independent quality assurance throughout the supply chain. Individuals who attended the webinar:
Valisure’s CEO, David Light and CSO, Kaury Kucera– in collaboration with Agilent, a global leader in manufacturing analytical laboratory equipment – participate in a webinar on identifying benzene in various ways consumer products and how Valisure provides independent quality assurance throughout the supply chain.
In late 2020, Valisure expanded its testing capabilities to include analysis for benzene and has since announced its detection of the carcinogen in multiple consumer products, including hand sanitizers, sunscreens, and body sprays, prompting several global recalls.
Valisure increasingly works directly with major stakeholders in healthcare, including purchasers and manufacturers of drug and consumer healthcare products, to infuse independent quality assurance throughout the supply chain. Individuals who attended the webinar:
Valisure’s CEO, David Light and CSO, Kaury Kucera– in collaboration with Agilent, a global leader in manufacturing analytical laboratory equipment – participate in a webinar on identifying benzene in various ways consumer products and how Valisure provides independent quality assurance throughout the supply chain.
In late 2020, Valisure expanded its testing capabilities to include analysis for benzene and has since announced its detection of the carcinogen in multiple consumer products, including hand sanitizers, sunscreens, and body sprays, prompting several global recalls.
Valisure increasingly works directly with major stakeholders in healthcare, including purchasers and manufacturers of drug and consumer healthcare products, to infuse independent quality assurance throughout the supply chain. Individuals who attended the webinar:
Valisure’s CEO, David Light and CSO, Kaury Kucera– in collaboration with Agilent, a global leader in manufacturing analytical laboratory equipment – participate in a webinar on identifying benzene in various ways consumer products and how Valisure provides independent quality assurance throughout the supply chain.
In late 2020, Valisure expanded its testing capabilities to include analysis for benzene and has since announced its detection of the carcinogen in multiple consumer products, including hand sanitizers, sunscreens, and body sprays, prompting several global recalls.
Valisure increasingly works directly with major stakeholders in healthcare, including purchasers and manufacturers of drug and consumer healthcare products, to infuse independent quality assurance throughout the supply chain. Individuals who attended the webinar: